Kura Oncology Inc —— 季度财务数据 (NASDAQ:KURA) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 269.13 M-71.93 M-28.78 M-80.63 M117.27 M -64.06 M 投资活动产生的现金 -94.95 M-101.41 M58.94 M93.97 M-64.6 M -13.1 M 融资活动产生的现金 806 K143 K515 K01.14 M 1.79 M 自由现金流 268.76 M-72.22 M-30.23 M-83.19 M114.95 M -70.7 M

新闻

Kura Oncology: Commercialization In AML Presents Asymmetric Upside (NASDAQ:KURA)

UBS因上市数据将Kura Oncology目标价下调至15美元

UBS lowers Kura Oncology stock price target to $15 on launch data

Kura Oncology在Leerink全球医疗保健会议上的战略扩张洞察

Kura Oncology at Leerink Global Healthcare Conference: Strategic Expansion Insights

Kura Oncology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:KURA) 2026-03-06

Citizens重申Kura Oncology股票评级,看好强劲上市表现

Citizens reiterates Kura Oncology stock rating on strong launch

Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates

Kura OncologyQ1每股收益及营收逊于预期

Kura Oncology Inc earnings missed by $0.66, revenue fell short of estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline